Improving Migraine Care: Migraine Comorbidity Assessment
NeurologyImproving Migraine Treatment and Prevention
0.50 AMA PRA Category 1 Credit(s) ™
May 28, 2020
The accreditation for this activity has expired.
Primary Audience:
Neurologists, Primary care providers, Emergency medicine providers, Nurse practitioners, Physician assistants, Nurses
Relevant Terms:
Migraine, headaches
Jessica Ailani, MD, FAHS, FAAN
Director, MedStar Georgetown Headache Center
Professor of Clinical Neurology
Department of Neurology
MedStar Georgetown University Hospital
Washington, DC
Dr. Ailani is a professor of clinical neurology at MedStar Georgetown University Hospital and director of the MedStar Georgetown Headache Center. Dr. Ailani treats a spectrum of headaches types including migraines, cluster headaches, tension headaches, posttraumatic headaches, occipital neuralgia, headache related to neck strain, and concussion-related headaches.
Dr. Ailani is involved in a number of clinical trials of several potential new agents for migraine.
| 1. | Incorporate evidence-based screening for comorbidities in all migraine patients | 2. | Select treatment to manage comorbidities and migraine |
| 1. | Incorporate evidence-based screening for comorbidities in all migraine patients |
| 2. | Select treatment to manage comorbidities and migraine |
Course Information
Provided by Albert Einstein College of Medicine-Montefiore Medical Center
Joint Accreditation Statement
In support of improving patient care, Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Credit Designation Statement
Albert Einstein College of Medicine-Montefiore Medical Center designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosures
Albert Einstein College of Medicine-Montefiore Medical Center requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. The Albert Einstein College of Medicine-Montefiore Medical Center also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device, not yet approved in the United States. All identified COI are thoroughly vetted and resolved according to Albert Einstein College of Medicine-Montefiore Medical Center policy. Albert Einstein College of Medicine-Montefiore Medical Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Peer Reviewer
David M. Kaufman, MD
Professor of Neurology and Psychiatry
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY
David Kaufman, MD has no relevant conflicts of interest to report.
The planners reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Wendy Gloffke, PhD, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Anne Roc, PhD, has no relevant conflicts of interest to report.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Jessica Ailani, MD, FAHS, FAAN, has disclosed that she has received consulting fees from Allergan, Amgen, Biohaven, Impel, Lilly, Lundbeck, Revance, Satsuma, Teva, Theranica, and Zosano; funds for research support from Allergan, Biohaven, Lilly, and Zosano; and fees for non-CME/CE services from Allergan, Amgen, Biohaven, Lilly, Lundbeck, and Teva.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Commercial Support Statement:
This activity is supported by educational funding provided by Amgen.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
